Cartesian Therapeutics
Price & Volume
Stats
See more52W Range | $5.98-$26.50 |
Market Cap | $196.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | -99.1% |
Gross Profit (12 Mos) | -$45.4M |
Diluted EPS | -$0.68 |
News
See moreYahoo Finance • 10 days ago
Cartesian Therapeutics Announces New Employment Inducement Grants
Yahoo Finance • 11 days ago
CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight
Yahoo Finance • 2 months ago
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 4 months ago
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
About
CEO | Dr. Carsten Brunn Ph.D. |
Address | 7495 New Horizon Way, Frederick, MD, United States, 21703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 66 |
